Clinical Trials Browser

Phase 1 × diphenylcyclopropenone × Clear all

NCT05481658 2026-02-10

Diphencyprone Plus Immune Checkpoint Inhibition in the Treatment of Cutaneous Metastases

Phase 1 Recruiting

Cutaneous Metastases

NCT05438290 2024-05-06

DPCP to Treat Cutaneous Neurofibromas Associated With NF1

Phase 1 Completed

Neurofibromatosis 1, Neurofibromatoses

NCT01711684 2017-11-29

Treatment of Cutaneous Metastases With Diphenylcyclopropenone (DPCP)

Phase 1 Completed

Melanoma, Neoplasm Metastasis